Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices 52927 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Discussion 

Draft NUREG–2159 provides guidance 

to facilitate compliance with applicable 

provisions in Subpart D of Part 74 of 

title 10 of the Code of Federal 

Regulations (10 CFR), ‘‘Material Control 

and Accounting of Special Nuclear 

Material.’’ Draft NUREG–2159 provides 

guidance for fuel cycle and other 

licensees and applicants who may 

request authorization to hold SNM of 

moderate strategic significance. 

Generally, this draft guidance document 

discusses acceptable methods licensees 

and applicants may use to prepare and 

implement their fundamental nuclear 

material control plans, and how the 

NRC will review and inspect these 

plans. The draft NUREG is being made 

available for public comments to allow 

opportunity for further suggestions to 

improve its clarity and utility. 

Dated: September 20, 2021. 

James L. Rubenstone, 

Chief, Material Control and Accounting 

Branch, Division of Fuel Management, Office 

of Nuclear Material Safety and Safeguards. 

[FR Doc. 2021–20631 Filed 9–22–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2021–0087] 

Preparing Probabilistic Fracture 

Mechanics Submittals 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Draft regulatory guide; draft 

NUREG; request for comment. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is issuing for public 

comment a draft regulatory guide (DG), 

DG–1382, ‘‘Preparing Probabilistic 

Fracture Mechanics Submittals’’ and 

accompanying draft NUREG/CR–7278, 

‘‘Technical Basis for the use of 

Probabilistic Fracture Mechanics in 

Regulatory Applications.’’ This DG is 

proposed new Regulatory Guide (RG) 

1.245. This draft guide describes a 

framework to develop the contents of a 

licensing submittal that the staff of the 

NRC considers acceptable when 

performing probabilistic fracture 

mechanics (PFM) analyses in support of 

regulatory applications. The draft 

NUREG provides the technical basis for 

DG–1382. 

DATES: Submit comments by October 25, 

2021. Comments received after this date 

will be considered if it is practical to do 

so, but the NRC is able to ensure 

consideration only for comments 

received on or before this date. 

Although a time limit is given, 

comments and suggestions in 

connection with items for inclusion in 

guides currently being developed or 

improvements in all published guides 

are encouraged at any time. 

ADDRESSES: You may submit comments 

by any of the following methods; 

however, the NRC encourages electronic 

comment submission through the 

Federal Rulemaking website: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0087. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: Stacy.

Schumann@nrc.gov. For technical 

questions, contact the individuals listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• Mail comments to: Office of 

Administration, Mail Stop: TWFN–7A– 

06M, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001, ATTN: Program Management, 

Announcements and Editing Staff. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: 

Patrick Raynaud, telephone: 301–415– 

1987, email: Patrick.Raynaud@nrc.gov 

and Kyle Song, telephone: 301–415– 

3612, email: Kyle.Song@nrc.gov. Both 

are staff of the Office of Nuclear 

Regulatory Research at the U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2021– 

0087 when contacting the NRC about 

the availability of information for this 

action. You may obtain publicly 

available information related to this 

action by any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0087. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, at 

301–415–4737, or by email to 

pdr.resource@nrc.gov. DG–1382, the 

associated regulatory analysis, and Draft 

NUREG/CR–7278 may be found in 

ADAMS under Accession Nos. 

ML21034A328, ML21034A261, and 

ML21257A237, respectively. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents, is currently closed. You 

may submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 1– 

800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. (ET), 

Monday through Friday, except Federal 

holidays. 

B. Submitting Comments 

The NRC encourages electronic 

comment submission through the 

Federal Rulemaking website (https://

www.regulations.gov). Please include 

Docket ID NRC–2021–0087 in your 

comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at https://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Additional Information 

The NRC is issuing for public 

comment a draft guide in the NRC’s 

‘‘Regulatory Guide’’ series. This series 

was developed to describe methods that 

are acceptable to the NRC staff for 


lotter on DSK11XQN23PROD with NOTICES1
52928 Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices 

implementing specific parts of the 

agency’s regulations, to explain 

techniques that the staff uses in 

evaluating specific issues or postulated 

events, and to describe information that 

the staff needs in its review of 

applications for permits and licenses. 

The DG, entitled ‘‘Preparing 

Probabilistic Fracture Mechanics 

Submittals,’’ is temporarily identified by 

its task number, DG–1382. 

DG–1382 is accompanied by draft 

NUREG/CR–7278, ‘‘Technical Basis for 

the use of Probabilistic Fracture 

Mechanics in Regulatory Applications.’’ 

This draft NUREG provides the 

technical basis for the guidance 

recommended in DG–1382. The NRC is 

issuing the draft NUREG for public 

comment at the same time as the DG to 

allow for review of both documents. 

The NRC developed this DG to 

support the increasing trend toward the 

use of PFM in regulatory applications. It 

is intended to ensure that minimum 

expectations are clear with regard to the 

contents of PFM regulatory applications. 

This DG will increase the efficiency of 

reviews for regulatory applications that 

use PFM as a supporting technical basis 

by providing a set of common 

guidelines for reviewers and licensees. 

The staff is also issuing for public 

comment a draft regulatory analysis. 

The staff develops a regulatory analysis 

to assess the value of issuing or revising 

a regulatory guide as well as alternative 

courses of action. 

III. Backfitting, Forward Fitting, and 

Issue Finality 

DG–1382 and NUREG/CR–7278, if 

finalized, would not constitute 

backfitting as defined in section 50.109 

of title 10 of the Code of Federal 

Regulations (10 CFR), ‘‘Backfitting,’’ and 

as described in NRC Management 

Directive (MD) 8.4, ‘‘Management of 

Backfitting, Forward Fitting, Issue 

Finality, and Information Requests’’; 

would not constitute forward fitting as 

that term is defined and described in 

MD 8.4; or affect the issue finality of any 

approval issued under 10 CFR part 52. 

As explained in DG–1382, applicants 

and licensees would not be required to 

comply with the positions set forth in 

DG–1382. 

Dated: September 17, 2021. 

For the Nuclear Regulatory Commission. 

Meraj Rahimi, 

Chief, Regulatory Guide and Programs 

Management Branch, Division of Engineering, 

Office of Nuclear Regulatory Research. 

[FR Doc. 2021–20566 Filed 9–22–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 50–608; NRC–2021–0140] 

SHINE Medical Technologies, LLC; 

SHINE Medical Isotope Production 

Facility 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: License amendment application; 

opportunity to request a hearing and 

petition for leave to intervene; order 

imposing procedures. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is considering 

issuance of an amendment to 

Construction Permit No. CPMIF–001, 

issued to SHINE Medical Technologies, 

LLC, for the construction of the SHINE 

Medical Isotope Production Facility. 

The proposed amendment would allow 

the receipt and possession of certain 

radioactive materials necessary for the 

continued construction of the SHINE 

Medical Isotope Production Facility. 

Because this amendment request 

contains sensitive unclassified nonsafeguards information (SUNSI), an 

order imposes procedures to obtain 

access to SUNSI for contention 

preparation. 

DATES: A request for a hearing or 

petitions for leave to intervene must be 

filed by November 22, 2021. Any 

potential party as defined in § 2.4 of title 

10 of the Code of Federal Regulations 

(10 CFR) who believes access to SUNSI 

is necessary to respond to this notice 

must request document access by 

October 4, 2021. 

ADDRESSES: Please refer to Docket ID 

NRC–2021–0140 when contacting the 

NRC about the availability of 

information for this action. You may 

obtain publicly available information 

related to this action by any of the 

following methods: 

• Federal Rulemaking website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0140. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: Stacy.

Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. The license amendment request 

is available in ADAMS under Accession 

No. ML21119A168. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents, is currently closed. You 

may submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 

1–800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. Eastern 

Time (ET), Monday through Friday, 

except Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

Steven Lynch, Office of Nuclear Reactor 

Regulation, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–415–1524, email: 

Steven.Lynch@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

The NRC is considering issuance of an 

amendment to Construction Permit No. 

CPMIF–001, issued to SHINE Medical 

Technologies, LLC, for construction of 

the SHINE Medical Isotope Production 

Facility, located in Rock County, 

Wisconsin. 

The proposed amendment would 

allow the receipt and possession of 

certain radioactive materials necessary 

for the continued construction of the 

SHINE Medical Isotope Production 

Facility. 

Before any issuance of the proposed 

amendment, the NRC will need to make 

the findings required by the Atomic 

Energy Act of 1954, as amended (the 

Act), and NRC’s regulations. 

II. Opportunity To Request a Hearing 

and Petition for Leave To Intervene 

Within 60 days after the date of 

publication of this notice, any person 

(petitioner) whose interest may be 

affected by this action may file a request 

for a hearing and petition for leave to 

intervene (petition) with respect to the 

action. Petitions shall be filed in 

accordance with the Commission’s 

‘‘Agency Rules of Practice and 

Procedure’’ in 10 CFR part 2. Interested 

persons should consult 10 CFR 2.309. 

The NRC’s regulations are accessible 

electronically from the NRC Library on 

the NRC’s website at https://

www.nrc.gov/reading-rm/doccollections/cfr/. If a petition is filed, the 

presiding officer will rule on the 

petition and, if appropriate, a notice of 

a hearing will be issued. 

As required by 10 CFR 2.309(d) the 

petition should specifically explain the 

reasons why intervention should be 

permitted with particular reference to 


lotter on DSK11XQN23PROD with NOTICES1